SCHEMBL29513596

SCHEMBL29513596

C[Si](C)(C)CCOCn1cc(Br)c2ccc(Cl)nc21

nearest known ligand 0.44

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 5/20 0.41
PDE10A Q9Y233 2/20 0.34
NPC1 O15118 1/20 0.33
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25345695 1.00 DGAT1 (0.41) DGAT1PDE10ANPC1MAPT
SCHEMBL29659291 0.85 DGAT1 (0.38) DGAT1PDE10ANPC1MAPT
SCHEMBL30461589 0.85 MTNR1A (0.37) DGAT1PDE10ANPC1MAPT
SCHEMBL25420978 0.85 MTNR1A (0.37) DGAT1PDE10ANPC1MAPT
SCHEMBL20455667 0.85 DGAT1 (0.38) DGAT1PDE10ANPC1MAPT
SCHEMBL25345296 0.82 DGAT1 (0.36) DGAT1PDE10ANPC1MAPT
SCHEMBL29513573 0.82 DGAT1 (0.36) DGAT1PDE10ANPC1MAPT
SCHEMBL25420967 0.81 DGAT1 (0.43) DGAT1PDE10AMAPT
SCHEMBL30461686 0.81 DGAT1 (0.43) DGAT1PDE10AMAPT
SCHEMBL25240181 0.81 DGAT1 (0.38) DGAT1NPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076973-A1 7-AZAINDOLE COMPOUNDS FOR INHIBITION OF BCR-ABL TYROSINE KINASES ENLIVEN THERAPEUTICS, INC. (US) 2022-04-14 WO disclosed